Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies
Authors
Keywords
Schlafen 11, SLFN11, ATR, DNA-targeting agent, DNA damage response, Replication stress, Topoisomerases, Cell cycle checkpoint, PARP inhibitors, Drug resistance
Journal
PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-05-23
DOI
10.1016/j.pharmthera.2019.05.009

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.